Clinical Trials Browser

BHQ880 × Plasma cell × Clear all

NCT01302886 2020-12-17

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Phase 2 Completed

Smoldering Multiple Myeloma

NCT01337752 2020-12-17

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

Phase 2 Completed

Multiple Myeloma, Renal Insufficiency

NCT00741377 2013-02-18

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Phase 1 Completed

Bone Diseases, Multiple Myeloma